Metformin Hydrochloride and Aspirin in Treating Patients With Hormone-Dependent Prostate Cancer That Has Progressed After Surgery or Radiation Therapy

NCT02420652 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

27

Enrollment

OTHER

Sponsor class

Stopped Slow accrual

Conditions

Recurrent Prostate Carcinoma
Stage I Prostate Cancer
Stage IIA Prostate Cancer
Stage IIB Prostate Cancer
Stage III Prostate Cancer

Interventions

DRUG: Aspirin
OTHER: Laboratory Biomarker Analysis
DRUG: Metformin Hydrochloride
OTHER: Placebo
OTHER: Placebo

Sponsor

Rutgers, The State University of New Jersey

Collaborators

[object Object]
[object Object]